智通财经APP讯，高视医疗(02407)发布公告，于近日，公司全资附属公司高视创新科技有限公司(“高视创新”)自主研发的型号为T3-600及T3-400的角膜共聚焦显微镜取得由江苏省药品监督管理局批准的医疗器械注册证。
该角膜共聚焦显微镜通过技术创新实现行业突破，成为国内同类设备中首款兼具宽视场与高分辨率。该设备采用激光光源和断层共焦扫瞄技术，将扫瞄视场提升至600×600μm，光学分辨率达1.1μm及数字分辨率达0.4μm，显着提高成像质量。角膜共聚焦显微镜可活体观察角膜及结膜，辅助诊断多种角结膜疾病：感染性疾病、非感染性疾病包括角膜变性、营养不良、免疫性病变、圆锥角膜，以及手术相关、外伤、干眼、全身病相关角膜病变等，为疾病诊断、病情评估提供依据。
高视创新已为T3产品规划AI功能拓展路径，后续将通过AI实现图像自动分析等功能，提升诊断效率与精准度，同时T3产品已同步启动CE注册流程。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.